Ram It, To The Moon: Dietary Supplements for Male Sexual Enhancement — FDA announcement Jun 11, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jun 11, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Dietary Supplements for Male Sexual Enhancement
Reason
Product is tainted with sildenafil and tadalafil
Classification
Not supplied
Recalling firm
Integrity Products
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
292b2c1716b31df7

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityIntegrity Products , St Louis MO is voluntarily recalling tainted lot (HGW221116) within expiry of the Ram It & To The Moon capsules to the consumer level. FDA analysis founds these products to be tainted with sildenafil and Tadalafil. Sildenafil/Tadalafil is an FDA approved drug for the treatment of erectile dysfunction, the presence of sildenafil in the Ram It & To The Moon products renders them unapproved drugs for which safety and efficacy have not been established, therefor subject to recall.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The product is marketed as dietary supplements for male sexual enhancement and is packaged in a blister card. 10 count boxes. Ram It & To The Moon were distributed to consumers nationwide via the Internet. We are notifying the public through this public announcement due to lack of ability to identify customers who may have received the product. Integrity Products. is notifying its customers that have the Ram It & To The Moon products to stop use and properly discard the product.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Fda listing date
Jun 11, 2024
Company announcement date
Feb 1, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records